they need to do that because FDA considers 2 point IPSS improvement as a primary endpoint and even though their P3 BPH were successful and had statistically significant results I think the result was less than 2 points on IPSS scale
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.